Acyclovir Dosing for HSV Encephalitis in Hemodialysis Patients
For HSV encephalitis in patients on hemodialysis, administer acyclovir 5-10 mg/kg IV every 24 hours (after each dialysis session), with an additional dose administered immediately after each dialysis treatment.
Dosing Algorithm for Dialysis Patients
Standard HSV Encephalitis Dose (Normal Renal Function)
- Adults: 10 mg/kg IV every 8 hours for 14-21 days 1, 2
- This is the established dose that reduced mortality from 70% to 20-30% in landmark trials 3
Adjusted Dose for Hemodialysis
Based on FDA labeling and guideline recommendations 4, 2:
Dosing regimen:
- 5-10 mg/kg IV every 24 hours (50% of normal dose at extended interval)
- Critical: Administer one additional full dose immediately after each dialysis session
- Hemodialysis removes approximately 60% of acyclovir over 6 hours, with a dialysis half-life of ~5 hours 2
Practical Implementation
Timing strategy:
- Schedule the daily maintenance dose to occur immediately post-dialysis
- This single post-dialysis dose serves as both the maintenance dose AND the supplemental dialysis dose
- On non-dialysis days, give the dose at the same time of day
Example schedule:
- Dialysis days (M/W/F): 10 mg/kg IV immediately after dialysis
- Non-dialysis days (T/Th/Sa/Su): 10 mg/kg IV at same time as dialysis days
Critical Safety Considerations
Nephrotoxicity Risk
Acyclovir causes reversible obstructive nephropathy in up to 20% of patients through crystalluria, typically manifesting after 4 days of therapy 3. While dialysis patients already have renal failure, proper dosing prevents:
- Acyclovir neurotoxicity (encephalopathy, hallucinations, myoclonus)
- Drug accumulation leading to seizures
Warning Signs of Acyclovir Toxicity in Dialysis Patients
- Altered consciousness or confusion
- Visual hallucinations
- Myoclonus or asterixis
- Agitation or disorientation
These symptoms can occur even with dose-adjusted acyclovir 6. If toxicity develops, increase dialysis frequency temporarily (daily hemodialysis normalizes levels within 3 sessions) 5.
Peritoneal Dialysis Caveat
CAPD provides significantly poorer acyclovir clearance than hemodialysis 6. If a peritoneal dialysis patient develops acyclovir encephalopathy:
- Temporarily switch to hemodialysis for faster drug removal
- CAPD patients have higher toxicity risk and slower recovery 6
Treatment Duration
Continue IV acyclovir for 14-21 days minimum 1:
- Perform repeat lumbar puncture at 14-21 days
- Check CSF HSV PCR at end of treatment
- If CSF remains PCR-positive, continue IV acyclovir with weekly PCR monitoring until negative 1
- Relapse rates are significant with shorter courses (<14 days)
Do not use oral acyclovir or valacyclovir for HSV encephalitis - they do not achieve adequate CSF levels 1.
Infusion Guidelines
Per FDA labeling 2:
- Infuse over 1 hour at constant rate - never give as bolus or rapid injection
- Reconstitute to 50 mg/mL, then dilute to ≤7 mg/mL for infusion
- Ensure adequate hydration during infusion
- Avoid intramuscular or subcutaneous routes
Monitoring Parameters
- Renal function (though already on dialysis, monitor for residual function)
- Neurological status for both disease progression and drug toxicity
- Ensure dialysis occurs as scheduled to prevent drug accumulation
- CSF HSV PCR at 14-21 days to guide duration 1
Key Pitfall to Avoid
The most common error is using the standard 200 mg PO every 12 hours dose listed in some renal dosing tables 4. This is for HSV suppression/prophylaxis, NOT encephalitis treatment. HSV encephalitis requires the full IV dose (10 mg/kg) adjusted for dialysis timing, not the low oral prophylactic dose.